Suppression of hepatic lymphokine-activated killer cell induction by murine kupffer cells and hepatocytes
Open Access
- 1 October 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 12 (4), 644-652
- https://doi.org/10.1002/hep.1840120404
Abstract
Murine lymphokine-activated-killer cell activity was readily induced by culturing spleen cells with 10 U/ml of interleukin-2 for 4 days. In contrast, very little activity was generated under the same culture conditions when nonparenchymal liver cells were used as the responding cells. It was concluded that Kupffer cells produced prostaglandin and interferon α/β, which suppressed lymphokine-activated-killer induction because (a) induction of lymphokine-activated-killer activity from nonparenchymal liver cells was observed in the presence of indomethacin and anti-interferon α/β antibody; (b) when adherent nonparenchymal liver cells, primarily Kupffer cells, were removed, lymphokine-activated-killer activity could be obtained with interleukin-2 alone; (c) coculture of Kupffer cells with nonadherent nonparenchymal liver cells in a two-chambered system inhibited lymphokineactivated killer cell induction in a dose-dependent manner; (d) exogenous prostaglandin E2 and interferon α/β added at the start of culture inhibited interleukin-2—induced cytotoxicity and proliferation, whereas the other major prostaglandin species in the liver, prostaglandin D2, had little effect. These findings are distinctive with Kupffer cells because splenic macrophages did not exert such inhibition in parallel experiments. Moreover, the supernatant collected from the 24-hr culture of nonparenchymal liver cells contained greater than 20-fold more prostaglandin E2 and interferon α/β than that from culture of spleen cells. In subsequent in vivo experiments, when interleukin-2 was given intraperitoneally to mice, the combination of indomethacin and anti-interferon α/β antibody significantly enhanced lymphokine-activated-killer activity recovered from the liver. Besides Kupffer cells, it was found that hepatocytes, the major cellular component of the liver, also played an inhibitory role on lymphokine-activated-killer cell generation. A cell-free liver cytosolic extract had even more potent suppressive effect, which was partially reversed by supplementation of arginine, indicating that arginase may be one of the hepatocyte-derived immunoinhibitors. (HEPATOLOGY 1990;12:644-652).This publication has 34 references indexed in Scilit:
- Immunotherapy of cancer using interleukin 2: current status and future prospectsImmunology Today, 1988
- Identification of prostaglandin D2 as the major eicosanoid from liver endothelial and Kupffer cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleenImmunology Today, 1987
- The regulatory effect of adherent cells on lymphokine activated killer cellsCellular Immunology, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Large granular lymphocytes or “Pit cells” from rat liver: isolation, ultrastructural characterization and natural killer activityEuropean Journal of Immunology, 1987
- Synergism between Alpha-Interferon and Interleukin-2-Activated Killer Cells: In vitro StudiesActa Haematologica, 1987
- Production of Two Distinct and Independent Hepatic Immunoregulatory Molecules by the Perfused Rat LiverHepatology, 1985
- Suppression of Lymphocyte Activation by A Protein Released From Isolated Perfused Rat LiverHepatology, 1982
- A lymphocyte-inhibiting factor isolated from normal human liverNature, 1974